All News
Media Articles
Press Releases
Publications & Posters
Newly-filed patent will enable platform technology to be licensed for much-needed biomarker assessment in pharmaceutical and healthcare industries VANCOUVER, BC, June…
Read More
Ed Smith brings experience in a range of top advisory roles across the UK’s public and private healthcare sectors VANCOUVER,…
Lord O’Shaughnessy brings a wealth of experience in healthcare policy, government and life sciences, as well as a broad network…
Professor Aarsland will assist Cognetivity by providing scientific expertise and access to extensive network of clinical and industry connections VANCOUVER,…
Cognetivity’s unique cognition-monitoring technology to be deployed to measure positive impact of employee wellness initiatives, enabling direct feedback and program…
Cognetivity joins select group of UK scaleups deemed capable of achieving at least 50% annual growth VANCOUVER, BC, Feb. 11, 2021 /CNW/…
Cognetivity’s iPad-based Integrated Cognitive Assessment (ICA) well suited to remote use as global demand for telehealth continues to surge VANCOUVER,…
Cognetivity reached several major milestones including first clinical deployment of its technology within the UK’s NHS, providing a strong platform…
Cognetivity one of only seven health tech innovators selected to advance to full accelerator program Cohorts receive increased resources and…
Research will utilise Cognetivity’s Integrated Cognitive Assessment (ICA) technology to study potential early-stage cognitive decline in individuals at risk of…
Integrated Cognitive Assessment’s speed, ease of administration and lack of learning effect enable monitoring of NHS patients with mild cognitive…
Admission onto platform streamlines adoption of Integrated Cognitive Assessment technology by NHS organisations VANCOUVER, BC, Oct. 13, 2020 /CNW/ – Cognetivity Neurosciences…
Texas Medical Centre innovation program aims to accelerate market access to US healthcare system for visionary medical device and digital…
Company’s cognitive assessment platform being used in renowned specialist NHS mental health Trust to improve dementia assessment VANCOUVER, BC, Sept. 29,…
New results published at major dementia conference further validate company’s ICA platform’s capabilities and suitability for early disease detection VANCOUVER,…
We investigated the link between participant’s performance in ICA test and their cortical volume and thickness; we were further interested…
Electroencephalography (EEG) has been commonly used to measure brain alterations in the early stage of Alzheimer’s disease. However the reported…
The Integrated Cognitive Assessment (ICA) test is based on humans’ strong reaction to animal stimuli, and the ability of a…
VANCOUVER, May 26, 2020 /CNW/ – Cognetivity Neurosciences Ltd. (the “Company” or “Cognetivity”) (CSE: CGN; FWB: 1UB; OTCQB: CGNSF) today announced the…
Background: Cognitive impairment is common in patients with multiple sclerosis (MS). Accurate and repeatable measures of cognition have the potential…
VANCOUVER, April 1, 2020 /CNW/ – Cognetivity Neurosciences Ltd. (the “Company” or “Cognetivity”) (CSE: CGN; FWB: 1UB; OTCQB: CGNSF) is continuing to…
VANCOUVER, Feb. 18, 2020 /CNW/ – Cognetivity Neurosciences Ltd. (the “Company” or “Cognetivity”) (CSE: CGN; FWB: 1UB; OTCQB: CGNSF) has today reported…
VANCOUVER, Jan. 21, 2020 /CNW/ – Cognetivity Neurosciences Ltd. (the “Company” or “Cognetivity”) (CSE: CGN; FWB: 1UB; OTCQB: CGNSF) today announced that…
Cognetivity Neurosciences announces regulatory approval of first CE-marked medical device Vancouver, British Columbia, January 7, 2020 – Cognetivity Neurosciences…
Regulatory approval will establish the company’s first CE-marked product. CE marking allows sale of device for medical environments across Europe. VANCOUVER, Dec….
RAZOR reporters visit a company that has developed an AI detector to pick up early signs of dementia
“London-based firm Cognetivity Neurosciences has developed a simple five-minute iPad-based test that can spot the early signs of dementia. With…
VANCOUVER, Nov. 13, 2019 /CNW/ – Cognetivity Neurosciences Ltd. (the “Company” or “Cognetivity”) (CSE: CGN; FWB: 1UB; OTCQB: CGNSF) today announced the…
VANCOUVER, Oct. 29, 2019 /CNW/ – Cognetivity Neurosciences Ltd. (the “Company” or “Cognetivity”) (CSE: CGN; FWB: 1UB; OTCQB: CGNSF) today confirmed that…
Innovate UK awards prestigious CA $1.3 million grant to Cognetivity to develop early dementia detection technology in UK National Health Service Cognetivity…
Tom Sawyer, Chief Operating Officer of Cognetivity told The Sociable that their test could be saving time and money by catching…
Cognetivity Neurosciences announces significant expansion of its UK NHS based clinical trial centers
VANCOUVER, Oct. 10, 2019 /CNW/ – Cognetivity Neurosciences Ltd. (the “Company” or “Cognetivity”) (CSE: CGN; FWB: 1UB; OTCQB: CGNSF) has confirmed positive…
VANCOUVER, Sept. 12, 2019 /CNW/ – Cognetivity Neurosciences Ltd. (the “Company” or “Cognetivity”) (CSE: CGN; FWB:1UB; OTCQB: CGNSF) announced that results from its research…
VANCOUVER, Sept. 10, 2019 /CNW/ – Cognetivity Neurosciences Ltd. (the “Company” or “Cognetivity”) (CSE: CGN; FWB:1UB; OTCQB: CGNSF) today announced that its technology…
The total number of people with dementia in China projected to reach 14.1 million by 2020 and 23.3 million by 2030. Annual…
Listen to doctor Thomas Sawyer, COO @ Cognetivity talk about an innovative digital platform platform (leveraging image recognition and Artificial…
Quatz’s health and science reporter takes a look at how visual tests may be the key to detecting dementia
Neuroscience Innovator, Cognetivity Neurosciences, Looks At Early Diagnosis From New Angle
Web content editor for Digital Health Age Ian Bolland caught up with Cognetivity COO Dr Tom Sawyer following results from…
Neurocentral talks to Cognetivity’s CEO, Sina Habibi about the company’s newly developed test, discussing where he hopes to see the…
A summary of Cognetivity’s recent work has been included in BioSpace’s weekly roundup up of Global Medical startups and companies…
AAIC is the Largest and Most Influential International Meeting Dedicated to Advancing Dementia Science Cognetivity’s Chief Medical Officer to Present Latest…
Introduction: Neurodegenerative disorders, such as Alzheimer’s Disease (AD), continue to present a major economic, social and healthcare burden. These diseases…
Cognetivity’s Chief Scientific Officer and Co-Founder, Dr. Seyed-Mahdi Khaligh-Razavi will presented results detailing the ICA platform’s ability to detect subtle changes…
New Research Provides Further Scientific Validation of the ICA Test’s Unique Capabilities in Early Stage Detection of Alzheimer’s Disease ICA…
Smart technologies will one day transform the detection, care and treatment of dementia, says Thomas Sawyer. He looks at what…
VANCOUVER, May 2, 2019 /CNW/ – Cognetivity Neurosciences Ltd. (the “Company” or “Cognetivity”) (CSE: CGN; FWB:1UB; OTCQB: CGNSF) announced today the appointment of…
Techworld spoke to the Cognetivity founder about developing a new tool for rapid dementia diagnosis
Medtech co-founder Dr Sina Habibi explains how the business is turning medical theory into practice
A five-minute online iPad test, which examines the speed and accuracy of a person’s thinking, could help healthcare professionals diagnose…
A FIVE-minute iPad test could detect dementia years before sufferers show any symptoms. Participants are asked which of 100 images…
The test could raise a warning when people’s reactions are slow or incorrect Scientists hope it could spot the effects…
A five-minute test may lead to more effective treatments — and could be rolled out across the health service next…
Cognetivity to present new, validated data demonstrating strong correleation with its ICA software test results and blood biomarkers associated with…
As CEO of Cognetivity Neurosciences, Sina Habibi simplifies complex challenges associated with personalized medicine and develops compelling and collaborative solutions…
Introduction: Neurodegenerative disorders, such as Alzheimer’s Disease (AD), continue to represent a major economic, social and healthcare burden. These diseases…
ISO 13485 certification for medical device development a critical prerequisite for global regulatory applications Certification confirms Cognetivity’s internal quality systems…
Dell Technologies interviews Cognetivity’s COO – Tom Sawyer
Big Ideas: “An app that can detect dementia in its early stages, without the need of a doctor” with Dr….
Big Ideas: “An app that can detect dementia in its early stages, without the need of a doctor” with Dr….
VANCOUVER, Feb. 11, 2019 /CNW/ – Cognetivity Neurosciences Ltd. (the “Company” or “Cognetivity”) (CSE: CGN; FWB: 1UB; OTCQB: CGNSF) announces that it plans…
Groundbreaking results published in leading peer-reviewed scientific journal Important academic validation of underlying science behind Cognetivity’s cognitive assessment platform VANCOUVER, Jan….
London-based tech start-up uses AI to detect warning signs of dementia
The new Integrated Cognitive Assessment can be used as a valid and reliable tool to assess one’s cognitive performance.
ICA: Speed and Accuracy of Visual Processing as a Reliable Proxy to Cognitive Performance
Cognetivity joins eight other select industry companies including AstraZeneca, GlaxoSmithKline and Janssen, and ten leading academic institutions including University of Oxford, University…
Five Young Companies Making An Impact On The World To Watch In 2019
Company named as one of five young companies making an impact on the world to watch in 2019 Enormous potential…
DW interviews Tom Sawyer on the importance of early detection
Dr. Sina Habibi speaks with the BBC about Cognetivity’s platform technology, the ICA
Cognetivity’s CSO discusses the benefits of AI in improving healthcare outcomes
Dr Sina Habibi discusses the importance of the early diagnosis of dementia, taking us through his AI solution, Cognetivity
Chris Kalafatis presenting at the Royal College of Psychs International Conference – Birmingham 2018
Dr. Sina Habibi tells the BBC to ’Think about your customers’ needs from the start’
A nautical adventure or an animal safari could test the brain in more ways than one.
Dr. Sina Habibi talks about why he was inspired to co-found a medtech company that is developing testing products to support early…
Cognitive impairment is common in patients with multiple sclerosis (MS), and occurs in up to 65% of these patients. However,…
The human visual system is developed by viewing natural scenes. In controlled experiments, natural stimuli therefore provide a realistic framework…
